Nina Lindholm

Ancora Biotech will use the funding to boost the clinical development of its trio of antibody treatments.

Immuta, which provides a cloud-based platform for enterprises to secure their data, announced a $100m series E funding round led by NightDragon. The round valued the company at more than $1 billion, according to a report by DealStreetAsia.

Delphia, a Toronto based algorithmic stock advisor, announced the completion of a $60 million Series A funding round led by Multicoin Capital.